These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15254025)

  • 21. Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus beta-lactamase-producing Enterobacteriaceae.
    Livermore DM; Mushtaq S; Ge Y
    J Antimicrob Chemother; 2010 Sep; 65(9):1972-4. PubMed ID: 20595207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
    Poirel L; Mammeri H; Nordmann P
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative activity of piperacillin/tazobactam against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Pagani L; Migliavacca R; Luzzaro F; Giacobone E; Perilli M; Micheletti P; Amicosante G
    Chemotherapy; 1998; 44(6):377-84. PubMed ID: 9755296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
    Walther-Rasmussen J; Høiby N
    Can J Microbiol; 2004 Mar; 50(3):137-65. PubMed ID: 15105882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.
    Jamieson CE; Lambert PA; Simpson IN
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2615-8. PubMed ID: 12878527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
    Kuo HY; Wang FD; Yen YF; Lin ML; Liu CY
    New Microbiol; 2009 Jan; 32(1):49-55. PubMed ID: 19382669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
    Franceschini N; Perilli M; Segatore B; Setacci D; Amicosante G; Mazzariol A; Cornaglia G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1459-62. PubMed ID: 9624494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies.
    Cullmann W
    Zentralbl Bakteriol; 1991 Oct; 275(4):500-3. PubMed ID: 1661596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A national multicenter study of the in-vitro activity of piperacillin-tazobactam. The Spanish Piperacillin-Tazobactam Group].
    Gobernado M; Bouza E; Perea E; Alvarez-Bravo J; García Rodríguez JA
    Rev Esp Quimioter; 1998 Jun; 11(2):139-46. PubMed ID: 9795299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugative resistance to tazobactam plus piperacillin among extended-spectrum beta-lactamase-producing nosocomial Klebsiella pneumoniae.
    Akhan S; Coskunkan F; Tansel O; Vahaboglu H
    Scand J Infect Dis; 2001; 33(7):512-5. PubMed ID: 11515761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of conalbumin on the activity of Syn 2190, a 1,5 dihydroxy-4-pyridon monobactam inhibitor of AmpC beta-lactamases.
    Babini GS; Livermore DM
    J Antimicrob Chemother; 2000 Jan; 45(1):105-9. PubMed ID: 10629020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.
    Nishida K; Kunugita C; Uji T; Higashitani F; Hyodo A; Unemi N; Maiti SN; Phillips OA; Spevak P; Atchison KP; Salama SM; Atwal H; Micetich RG
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1895-900. PubMed ID: 10428909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitors.
    Weiss WJ; Petersen PJ; Murphy TM; Tardio L; Yang Y; Bradford PA; Venkatesan AM; Abe T; Isoda T; Mihira A; Ushirogochi H; Takasake T; Projan S; O'Connell J; Mansour TS
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4589-96. PubMed ID: 15561830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
    Neu HC
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    London N; Thomson CJ; Amyes SG; Stobberingh E
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo efficacy of YTR-830H and piperacillin combinations versus beta-lactamase-producing bacteria.
    Kuck NA; Petersen PJ; Weiss WJ; Testa RT
    J Chemother; 1989 Jun; 1(3):155-61. PubMed ID: 2552030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.